EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Ivermectin as a potential therapeutic strategy for glioma

Xing Hu iD, Yan Ju, Yue-Kang Zhang

Journal of Neuroscience Research · 2024

DOI: 10.1002/jnr.25254 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Neuroscience Research, 2024. Verfasst von Xing Hu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu, PR China. Hauptthemen laut MEDLINE: Glioma, Antineoplastic Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 140 Literaturangaben. Gefördert von: the Science and Technology Supportive Project of Sichuan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ivermectin (IVM), a semi‐synthetic macrolide parasiticide, has demonstrated considerable effectiveness in combating internal and external parasites, particularly nematodes and arthropods. Its remarkable ability to control parasites has earned it significant recognition, culminating in Satoshi Omura and William C. Campbell's receipt of the 2015 Nobel Prize in Physiology or Medicine for their contributions to the development of IVM. In recent years, investigations have revealed that IVM possesses antitumor properties. It can suppress the growth of various cancer cells, including glioma, through a multitude of mechanisms such as selective targeting of tumor‐specific proteins, inducing programmed cell death, and modulation of tumor‐related signaling pathways. Hence, IVM holds tremendous potential as a novel anticancer drug. This review seeks to provide an overview of the underlying mechanisms that enable IVM's capacity to suppress glioma. Furthermore, it aims to elucidate the challenges and prospects associated with utilizing IVM as a new anticancer agent.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GliomaAntineoplastic AgentsHumansIvermectinNobel PrizeApoptosis

Stichwörter der Autor:innen

cancergliomaivermectinmechanisms

Substanzen

IvermectinAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu, PR China.

ORCID-Profile: Xing Hu

Förderung

  • the Science and Technology Supportive Project of Sichuan Province

Zitieren

APA

Hu, X., Ju, Y., & Zhang, Y. K. (2024). Ivermectin as a potential therapeutic strategy for glioma. Journal of Neuroscience Research. https://doi.org/10.1002/jnr.25254

Vancouver

Hu X, Ju Y, Zhang YK. Ivermectin as a potential therapeutic strategy for glioma. Journal of Neuroscience Research. 2024. doi:10.1002/jnr.25254

BibTeX
@article{Hu2024,
  author = {Hu, Xing and Ju, Yan and Zhang, Yue-Kang},
  title = {Ivermectin as a potential therapeutic strategy for glioma},
  journal = {Journal of Neuroscience Research},
  year = {2024},
  doi = {10.1002/jnr.25254}
}
Kostenlos starten →